candesartan has been researched along with Coarctation of Aorta in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giordano, U | 1 |
| Cifra, B | 1 |
| Giannico, S | 1 |
| Turchetta, A | 1 |
| Calzolari, A | 1 |
| Moltzer, E | 1 |
| Mattace Raso, FU | 1 |
| Karamermer, Y | 1 |
| Boersma, E | 1 |
| Webb, GD | 1 |
| Simoons, ML | 1 |
| Danser, AH | 1 |
| van den Meiracker, AH | 1 |
| Roos-Hesselink, JW | 1 |
1 trial available for candesartan and Coarctation of Aorta
| Article | Year |
|---|---|
Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Aortic Coarctation; Ben | 2010 |
1 other study available for candesartan and Coarctation of Aorta
| Article | Year |
|---|---|
Mid-term results, and therapeutic management, for patients suffering hypertension after surgical repair of aortic coarctation.
Topics: Adolescent; Antihypertensive Agents; Aortic Coarctation; Atenolol; Benzimidazoles; Biphenyl Compound | 2009 |